Filing Details
- Accession Number:
- 0001127602-17-023518
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-12 07:13:56
- Reporting Period:
- 2017-07-10
- Filing Date:
- 2017-07-12
- Accepted Time:
- 2017-07-12 07:13:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-07-10 | 100 | $99.19 | 342,298 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 200 | $99.19 | 342,098 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.20 | 341,998 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 200 | $99.20 | 341,798 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 5 | $99.21 | 341,793 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 912 | $99.21 | 340,881 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 1 | $99.22 | 340,880 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 613 | $99.22 | 340,267 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 200 | $99.23 | 340,067 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 200 | $99.25 | 339,867 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.26 | 339,767 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.26 | 339,667 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 300 | $99.27 | 339,367 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.28 | 339,267 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 99 | $99.29 | 339,168 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 249 | $99.30 | 338,919 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 40 | $99.32 | 338,879 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 700 | $99.32 | 338,179 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 101 | $99.33 | 338,078 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 300 | $99.37 | 337,778 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.40 | 337,678 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.40 | 337,578 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 300 | $99.41 | 337,278 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.42 | 337,178 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 100 | $99.54 | 337,078 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-07-10 | 400 | $99.62 | 336,678 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.